Benchmark analyst Matthew Harrigan maintains Comcast (NASDAQ:CMCSA) with a Buy and lowers the price target from $60 to $46.
Asensus Surgical Secures FDA 510(k) Clearance For Pediatric Indication For Senhance Surgical System
The Senhance System is already approved for pediatric patients in the EU and Japan.
